130 related articles for article (PubMed ID: 8952871)
1. Effect of acarbose on blood glucose profiles and plasma 1,5-anhydro-d-glucitol in type 2 diabetes poorly controlled by sulfonylurea therapy.
Hotta N; Koh N; Sakakibara F; Naruse K; Yamada T; Takeuchi N; Yamada K; Fukasawa H; Kakuta H
Biomed Pharmacother; 1996; 50(6-7):297-302. PubMed ID: 8952871
[TBL] [Abstract][Full Text] [Related]
2. [Effectiveness and tolerance of long-term acarbose therapy in diabetic patients with threatened secondary failure of sulfonylurea drug treatment].
Domke A; Willms B
Med Klin (Munich); 1994 Apr; 89(4):187-92. PubMed ID: 8015532
[TBL] [Abstract][Full Text] [Related]
3. [Effect of acarbose on carbohydrate and lipid metabolism in type II diabetes with secondary failure].
Heuer LJ; Kaufmann HH
Dtsch Z Verdau Stoffwechselkr; 1985; 45(2):52-8. PubMed ID: 3924553
[TBL] [Abstract][Full Text] [Related]
4. Influence of treatment with acarbose or glibenclamide on insulin sensitivity in type 2 diabetic patients.
Fischer S; Patzak A; Rietzsch H; Schwanebeck U; Köhler C; Wildbrett J; Fuecker K; Temelkova-Kurktschiev T; Hanefeld M
Diabetes Obes Metab; 2003 Jan; 5(1):38-44. PubMed ID: 12542723
[TBL] [Abstract][Full Text] [Related]
5. Plasma 1,5-anhydro-D-glucitol as new clinical marker of glycemic control in NIDDM patients.
Yamanouchi T; Minoda S; Yabuuchi M; Akanuma Y; Akanuma H; Miyashita H; Akaoka I
Diabetes; 1989 Jun; 38(6):723-9. PubMed ID: 2656341
[TBL] [Abstract][Full Text] [Related]
6. The effect of acarbose on blood glucose profiles of type 2 diabetic patients receiving insulin therapy.
Hotta N; Kakuta H; Koh N; Sakakibara F; Haga T; Sano T; Okuyama M; Sakamoto N
Diabet Med; 1993 May; 10(4):355-8. PubMed ID: 8508620
[TBL] [Abstract][Full Text] [Related]
7. Effect of acarbose on glycemic control, serum lipids and lipoproteins in type 2 diabetes.
Mughal MA; Memon MY; Zardari MK; Tanwani RK; Ali M
J Pak Med Assoc; 2000 May; 50(5):152-6. PubMed ID: 11242714
[TBL] [Abstract][Full Text] [Related]
8. Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus.
Vannasaeng S; Ploybutr S; Nitiyanant W; Peerapatdit T; Vichayanrat A
J Med Assoc Thai; 1995 Nov; 78(11):578-85. PubMed ID: 8576667
[TBL] [Abstract][Full Text] [Related]
9. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
Rosak C; Haupt E; Walter T; Werner J
Diabetes Nutr Metab; 2002 Jun; 15(3):143-51. PubMed ID: 12173728
[TBL] [Abstract][Full Text] [Related]
10. [Acarbose, an unduly neglected antidiabetic drug].
Iványi J; Gyimesi A
Orv Hetil; 1996 Dec; 137(49):2737-41. PubMed ID: 9679608
[TBL] [Abstract][Full Text] [Related]
11. [Clinical experience with an alpha glucosidase inhibitor (acarbose) in the treatment of non-insulin-dependent diabetes. Multicenter study].
García de los Ríos M; Mujica V; Muñoz S; Durruty P; Larenas G; López MI; Kuzmanic A; Pérez J; Flaskamp R; Cumsille F
Rev Med Chil; 1997 Aug; 125(8):856-62. PubMed ID: 9580485
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics, tolerability, and fructosamine-lowering effect of a novel, controlled-release formulation of alpha-lipoic acid.
Evans JL; Heymann CJ; Goldfine ID; Gavin LA
Endocr Pract; 2002; 8(1):29-35. PubMed ID: 11951812
[TBL] [Abstract][Full Text] [Related]
13. Blood glucose concentrations and glycosuria during and after one year of acarbose therapy.
Aubell R; Boehme K; Berchtold P
Arzneimittelforschung; 1983; 33(9):1314-8. PubMed ID: 6357206
[TBL] [Abstract][Full Text] [Related]
14. Effect of acarbose in treatment of type II diabetes mellitus: a double-blind, crossover, placebo-controlled trial.
Soonthornpun S; Rattarasarn C; Thamprasit A; Leetanaporn K
J Med Assoc Thai; 1998 Mar; 81(3):195-200. PubMed ID: 9623011
[TBL] [Abstract][Full Text] [Related]
15. Urinary excretion of 1,5-anhydro-D-glucitol accompanying glucose excretion in diabetic patients.
Akanuma Y; Morita M; Fukuzawa N; Yamanouchi T; Akanuma H
Diabetologia; 1988 Nov; 31(11):831-5. PubMed ID: 3234638
[TBL] [Abstract][Full Text] [Related]
16. Effect of acarbose on carbohydrate and lipid metabolism in NIDDM patients poorly controlled by sulfonylureas.
Reaven GM; Lardinois CK; Greenfield MS; Schwartz HC; Vreman HJ
Diabetes Care; 1990 Aug; 13 Suppl 3():32-6. PubMed ID: 2209341
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy of acarbose in diabetes mellitus: a critical review of controlled trials.
Scheen AJ
Diabetes Metab; 1998 Sep; 24(4):311-20. PubMed ID: 9805641
[TBL] [Abstract][Full Text] [Related]
18. [Effect of acarbose on postprandial increase in blood glucose. Additive acute effect of once daily administration in insulin treated diabetes].
Ledermann H; Höxter G
Fortschr Med; 1994 Nov; 112(32):467-70. PubMed ID: 7821886
[TBL] [Abstract][Full Text] [Related]
19. Triple oral antidiabetic therapy.
Kaye TB
J Diabetes Complications; 1998; 12(6):311-3. PubMed ID: 9877464
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects of intestinal alpha-glucosidase inhibition on postprandial glucose, pancreatic and gut hormone responses and fasting serum lipids in diabetics on sulphonylureas.
Uttenthal LO; Ukponmwan OO; Wood SM; Ghiglione M; Ghatei MA; Trayner IM; Bloom SR
Diabet Med; 1986 Mar; 3(2):155-60. PubMed ID: 2951158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
